713 related articles for article (PubMed ID: 30345709)
1. Unique patterns of glycosylation in immunoglobulin subclass G4-related disease and primary sclerosing cholangitis.
Culver EL; van de Bovenkamp FS; Derksen NIL; Koers J; Cargill T; Barnes E; de Neef LA; Koeleman CAM; Aalberse RC; Wuhrer M; Rispens T
J Gastroenterol Hepatol; 2019 Oct; 34(10):1878-1886. PubMed ID: 30345709
[TBL] [Abstract][Full Text] [Related]
2. The long-term outcomes of patients with immunoglobulin G4-related sclerosing cholangitis: the Mayo Clinic experience.
Ali AH; Bi Y; Machicado JD; Garg S; Lennon RJ; Zhang L; Takahashi N; Carey EJ; Lindor KD; Buness JG; Tabibian JH; Chari ST
J Gastroenterol; 2020 Nov; 55(11):1087-1097. PubMed ID: 32770464
[TBL] [Abstract][Full Text] [Related]
3. Recent advances in IgG4-related disease, autoimmune pancreatitis and sclerosing cholangitis.
Okazaki K; Uchida K
Nihon Rinsho; 2017 Mar; 75(3):450-454. PubMed ID: 30566790
[TBL] [Abstract][Full Text] [Related]
4. [Paying attention to the diagnosis and treatment of IgG4-related sclerosing cholangitis].
Li BL; Xiao JC
Zhonghua Wai Ke Za Zhi; 2019 Jul; 57(7):508-512. PubMed ID: 31269612
[TBL] [Abstract][Full Text] [Related]
5. Immunoglobulin G4-related sclerosing cholangitis.
Tanaka A
J Dig Dis; 2019 Jul; 20(7):357-362. PubMed ID: 31112324
[TBL] [Abstract][Full Text] [Related]
6. IgG4-related sclerosing cholangitis- A great mimicker.
Nayak HK; Bhat SJ; Panigrahi MK; Chouhan I; Kumar C; Samal SC
Indian J Gastroenterol; 2020 Dec; 39(6):614-618. PubMed ID: 33156480
[TBL] [Abstract][Full Text] [Related]
7. Clinical characteristics and outcome of IgG4-related disease with hypocomplementemia: a prospective cohort study.
Peng L; Lu H; Zhou J; Zhang P; Li J; Liu Z; Wu D; Zhang S; Yang Y; Bai W; Wang L; Fei Y; Zhang W; Zhao Y; Zeng X; Zhang F
Arthritis Res Ther; 2021 Apr; 23(1):102. PubMed ID: 33827676
[TBL] [Abstract][Full Text] [Related]
8. Serum immunoglobulin G4 and immunoglobulin G1 for distinguishing immunoglobulin G4-associated cholangitis from primary sclerosing cholangitis.
Boonstra K; Culver EL; de Buy Wenniger LM; van Heerde MJ; van Erpecum KJ; Poen AC; van Nieuwkerk KM; Spanier BW; Witteman BJ; Tuynman HA; van Geloven N; van Buuren H; Chapman RW; Barnes E; Beuers U; Ponsioen CY
Hepatology; 2014 May; 59(5):1954-63. PubMed ID: 24375491
[TBL] [Abstract][Full Text] [Related]
9. Immunoglobulins G from patients with ANCA-associated vasculitis are atypically glycosylated in both the Fc and Fab regions and the relation to disease activity.
Lardinois OM; Deterding LJ; Hess JJ; Poulton CJ; Henderson CD; Jennette JC; Nachman PH; Falk RJ
PLoS One; 2019; 14(2):e0213215. PubMed ID: 30818380
[TBL] [Abstract][Full Text] [Related]
10. Efficacy and safety of iguratimod plus corticosteroid as bridge therapy in treating mild IgG4-related diseases: A prospective clinical trial.
Zhang P; Gong Y; Liu Z; Liu Y; Lin W; Li J; Wang M; Liu X; Fei Y; Chen H; Peng L; Li J; Zhou J; Shi Q; Zhang X; Shen M; Zeng X; Zhang F; Li Y; Zhao Y; Zhang W
Int J Rheum Dis; 2019 Aug; 22(8):1479-1488. PubMed ID: 31245907
[TBL] [Abstract][Full Text] [Related]
11. A novel serum metabolomic panel distinguishes IgG4-related sclerosing cholangitis from primary sclerosing cholangitis.
Radford-Smith DE; Selvaraj EA; Peters R; Orrell M; Bolon J; Anthony DC; Pavlides M; Lynch K; Geremia A; Bailey A; Culver EL; Probert F
Liver Int; 2022 Jun; 42(6):1344-1354. PubMed ID: 35129255
[TBL] [Abstract][Full Text] [Related]
12. Sclerosing Cholangitis Related to IgG4: Not Always a Curable Entity.
Martínez-Valle F; Riveiro-Barciela M; Salcedo MT; Merino-Casabiel X; Fernández-Codina A; Torres I; Esteban R; Buti M
Ann Hepatol; 2019; 18(1):215-219. PubMed ID: 31113593
[TBL] [Abstract][Full Text] [Related]
13. Glycomic analysis of antibody indicates distinctive glycosylation profile in patients with autoimmune cholangitis.
Zhou X; Kailemia MJ; Sun Y; Shuai Z; Yang GX; Dhaliwal S; Cristoferi L; Leung PSC; Invernizzi P; Bowlus CL; Lebrilla CB; Ansari AA; Ridgway WM; Zhang W; Gershwin ME
J Autoimmun; 2020 Sep; 113():102503. PubMed ID: 32546343
[TBL] [Abstract][Full Text] [Related]
14. IgG4-Related Sclerosing Cholangitis and Primary Sclerosing Cholangitis.
Tanaka A
Gut Liver; 2019 May; 13(3):300-307. PubMed ID: 30205418
[TBL] [Abstract][Full Text] [Related]
15. Skewed Fc glycosylation profiles of anti-proteinase 3 immunoglobulin G1 autoantibodies from granulomatosis with polyangiitis patients show low levels of bisection, galactosylation, and sialylation.
Wuhrer M; Stavenhagen K; Koeleman CA; Selman MH; Harper L; Jacobs BC; Savage CO; Jefferis R; Deelder AM; Morgan M
J Proteome Res; 2015 Apr; 14(4):1657-65. PubMed ID: 25761865
[TBL] [Abstract][Full Text] [Related]
16. Immunoglobulin G4-related cholangitis: a variant of IgG4-related systemic disease.
Novotný I; Dítě P; Trna J; Lata J; Husová L; Geryk E
Dig Dis; 2012; 30(2):216-9. PubMed ID: 22722442
[TBL] [Abstract][Full Text] [Related]
17. Subclass-specific IgG glycosylation is associated with markers of inflammation and metabolic health.
Plomp R; Ruhaak LR; Uh HW; Reiding KR; Selman M; Houwing-Duistermaat JJ; Slagboom PE; Beekman M; Wuhrer M
Sci Rep; 2017 Sep; 7(1):12325. PubMed ID: 28951559
[TBL] [Abstract][Full Text] [Related]
18. IgG4-Associated Cholangitis--A Mimic of PSC.
Beuers U; Hubers LM; Doorenspleet M; Maillette de Buy Wenniger L; Klarenbeek PL; Boonstra K; Ponsioen C; Rauws E; de Vries N
Dig Dis; 2015; 33 Suppl 2():176-80. PubMed ID: 26641633
[TBL] [Abstract][Full Text] [Related]
19. Clinical manifestations, clinical course, and outcomes of immunoglobulin G4-related disease.
Phaopraphat K; Ngamjanyaporn P; Narongroeknawin P; Kasitanon N; Katchamart W
Int J Rheum Dis; 2020 Nov; 23(11):1468-1473. PubMed ID: 32808722
[TBL] [Abstract][Full Text] [Related]
20. Comparative clinical characteristics and natural history of three variants of sclerosing cholangitis: IgG4-related SC, PSC/AIH and PSC alone.
Lian M; Li B; Xiao X; Yang Y; Jiang P; Yan L; Sun C; Zhang J; Wei Y; Li Y; Chen W; Jiang X; Miao Q; Chen X; Qiu D; Sheng L; Hua J; Tang R; Wang Q; Eric Gershwin M; Ma X
Autoimmun Rev; 2017 Aug; 16(8):875-882. PubMed ID: 28564616
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
